Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

RAD001 – Anti-Cancer Therapy, Anti-neoplastic agent by Novartis

Cross-section of a solid tumour; Afinitor is undergoing clinical trials as a treatment for various tumours of this type. Afinitor has been approved for the treatment of renal cell cancer and advanced neuroendocrine tumours of pancreatic gastrointestinal, lung or pancreatic origin.

  • Cross-section of a solid tumour
  • Renal cell carcinoma (RCC)
  • Common secondary sites of RCC

Go Top